- ￥1668
- abinScience
- China
- HA659014
- 2026年03月03日
- ELISA, IHC, WB
- Rabbit
- Human, Bovine, Rabbit, Mouse, Rat, Zebrafish
企业认证
相关产品推荐更多 >
Research Grade Anti-Human OPN/SPP1 (ASK8007), 研究级Anti-Human OPN/SPP1 (ASK8007)
￥2588
Anti-ENO3 Polyclonal Antibody, 抗ENO3多克隆抗体
￥1008Research Grade Anti-Human CD279/PDCD1/PD1 (AMP-514), 研究级Anti-Human CD279/PDCD1/PD1 (AMP-514)
￥2588
Anti-Mouse CD370/CLEC9A Antibody (SAA0484), 抗小鼠CD370/CLEC9A抗体 (SAA0484)
￥1338Research Grade Anti-Human CD163 (TBI 304H), 研究级Anti-Human CD163 (TBI 304H)
￥2588
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Rabbit
- 亚型：
IgG
- 形态：
Liquid
- 保存条件：
0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
- 克隆性：
Polyclonal
- 标记物：
Unconjugated
- 适应物种：
Human, Bovine, Rabbit, Mouse, Rat, Zebrafish
- 保质期：
1 year
- 抗原来源：
Rabbit
- 目录编号：
HA659014
- 级别：
科研级别
- 库存：
999
- 供应商：
abinScience
- 宿主：
Rabbit
- 应用范围：
ELISA, IHC, WB
- 浓度：
1mg/mL
- 靶点：
Serine--tRNA ligase, cytoplasmic; 6.1.1.11; Seryl-tRNA synthetase; SerRS; Seryl-tRNA(Ser/Sec) synthetase; SARS1; SARS; SERS
- 抗体英文名：
Anti-SARS1 Polyclonal Antibody
- 抗体名：
Anti-SARS1 Polyclonal Antibody
- 规格：
100ul
| Product name | Anti-SARS1 Polyclonal Antibody |
|---|---|
| Catalog No. | HA659014 |
| Host species | Rabbit |
| Species reactivity | Human, Bovine, Rabbit, Mouse, Rat, Zebrafish |
| Immunogen | E. coli - derived recombinant human SARS1 (Ser142-Lys472). |
| Form | Liquid |
| Storage buffer | 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300. |
| Purity | / |
| Clonality | Polyclonal |
| Isotype | IgG |
| Applications | ELISA, IHC, WB |
| Target | Serine--tRNA ligase, cytoplasmic; 6.1.1.11; Seryl-tRNA synthetase; SerRS; Seryl-tRNA(Ser/Sec) synthetase; SARS1; SARS; SERS |
| Purification | Purified by antigen affinity column. |
| Endotoxin level | Please contact with the lab for this information. |
| Expression system | / |
| Accession | P49591, Q9GMB8, P13642, P26638, Q6P799, Q6DRC0 |
| Alternative Names | / |
| Clone ID | / |
| Species | / |
| Product Usage Information | ELISA:1:5000-1:20000;IHC:1:50-1:500;WB:1:500-1:2000 |
abinScience, founded in 2023 in Strasbourg, France, is committed to developing and producing high-quality life science reagents. Rooted in one of Europe’s leading hubs for scientific innovation, abinScience empowers global research through reliable, efficient experimental solutions. Guided by the vision of “Empowering Bioscience Discovery,” we support scientists worldwide in advancing the frontiers of bioscience.
Technology and Innovation
Relying on the global leading position in antibody and protein research and more than 20 years of industry experience of its parent company ProteoGenix since 2003, abinScience has inherited advanced technologies and high-quality standards. In particular, the XtenCHO™ system developed by ProteoGenix, which has two modes of transient expression and stable expression, has been widely recognized as a core technology to improve the efficiency of protein production, providing a solid foundation for abinScience's product research and development.
Product categories and application fields.
Main products.
10000+ high-activity proteins.
15000+ antibody series products:
Classic monoclonal antibody.
Monoclonal antibody
Internal control antibody, labeled antibody.
High-quality phosphorylation antibodies.
Highly specific nanobodies and small molecule antibodies.
Functional antibodies in vivo.
Low-background flow cytometry antibodies.
DNA/RNA antibodies and PEG antibodies.
1000+ reagent kit series products.
Large-scale packaging customization services: We offer personalized antibody design, protein production, molecular optimization, and experimental development services.
Application field
Infectious disease research: including viruses, superbugs, parasites, etc.
Neuroscience research: Supporting research on neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
Immunology research: Covers the research needs of immune activation, inhibition, and allergies and abnormal reactions.
Oncology research: Supporting the development of tumor biology and anti-tumor drugs.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验• tRNA ligase structure reveals kinetic competition between non-conventional mRNA splicing and mRNA decay., PMID:31237564
• Regulation of Archease by the mTOR-vATPase axis., PMID:36111596
• Eukaryotic AlaX provides multiple checkpoints for quality and quantity of aminoacyl-tRNAs in translation., PMID:38869066
• Insights into substrate promiscuity of human seryl-tRNA synthetase., PMID:28808125
• Regulation of BRCA1 stability through the tandem UBX domains of isoleucyl-tRNA synthetase 1., PMID:36347866
• The primary structures of three yeast mitochondrial serine tRNA isoacceptors., PMID:6819004
• Cytoplasmic methionyl-tRNA synthetase from Bakers' yeast. A monomer with a post-translationally modified N terminus., PMID:3905796
• Seryl-tRNA Synthetase Shows a Noncanonical Activity of Upregulating Laccase Transcription in Trametes hirsuta AH28-2 Exposed to Copper Ion., PMID:37395668
• Cloning and characterization of the gene coding for cytoplasmic seryl-tRNA synthetase from Saccharomyces cerevisiae., PMID:3031581
Polyclonal Antibody Production
, if desired this is best accomplished by Protein A Affinity Chromatography. 上一篇：make an Antibody against a Peptides 下一篇：Immunization Protocol for Monoclonal Antibody Production
全球首次！分离的新冠病毒中和抗体，还可同时抗 SARS 病毒
的特效药。对于此次的 COVID- 19 而言，目前也缺乏治疗该疾病的疫苗和靶向疗法。2020 年 3 月 11 日，来自荷兰乌得勒支大学的 Berend-Jan Bosch 教授团队在预印本杂志 bioRxiv 发表了题为《A human monoclonal antibody blocking SARS-CoV- 2 infection》的研究论文。该研究报告了一种能够同时中和 SARS-CoV- 2 和 SARS-CoV 的全人源单克隆抗体。研究人员称这种交叉中和抗体能够靶向这些病毒的共同
Polyclonal Antibody Production
Polyclonal Antibody Production Very useful for rapid and simple generation of antibodies for western blots, ELISA assays, and immunoprecipitation. Rabbit Immunization Initial Preparation Your antigen
技术资料暂无技术资料 索取技术资料
